Page 7 - 2021 Taiwan Food and Drug Administration Annual Report
P. 7
The Taiwan Food and Drug Adminis- in response to the imbalance in the supply
tration (TFDA) of the Ministry of Health DQG GHPDQG RI PDVNV GXULQJ WKH SDQGHPLF
and Welfare was established to promote ev- the CECC coordinated efforts between the
ery citizen’s health and the public welfare. public and private sectors to establish the
Based on its mission of “Providing safe and Mask Rationing Plan and quickly solve prob-
H൵HFWLYH PHGLFLQHV VDIH DQG KHDOWK\ IRRG´ lems to improve the self-defense capabilities
TFDA aims to become a trusted guardian against the pandemic for everyone.
RI IRRG DQG PHGLFLQH VDIHW\ IRU WKH SHRSOH
PDQDJLQJ WKH SROLFLHV IRU IRRG PHGLFLQH During the joint fight against the pan-
PHGLFDO GHYLFHV DQG FRVPHWLFV ZKLFK HQVXUH GHPLF 7)'$ KDV DFKLHYHG JUHDW UHVXOWV
that the people are guaranteed the safety in refining various works. In terms of food
and quality of food and medicine. In order VDIHW\ PDQDJHPHQW 7)'$ KDV LPSOHPHQW-
to document relevant important policies and HG VHYHUDO PHDVXUHV LQFOXGLQJ DQQRXQFLQJ
LPSOHPHQWDWLRQ 7)'$ SUHSDUHV DQ DQQXDO FRPSUHKHQVLYH UHJXODWLRQV HQKDQFLQJ WKH
report that summarized various important VXSHUYLVLRQ RI PDQXIDFWXULQJ VDOH LPSRUW
SROLFLHV SODQV DQG DFKLHYHPHQWV LQ WKH SUH- DQG H[SRUW DQG LPSURYLQJ DGYDQFHG LQVSHF-
YLRXV \HDU SXEOLVKLQJ WKHP GRPHVWLFDOO\ DQG tion technologies and big data risk analysis
internationally for reference. FDSDELOLWLHV WR UHLQIRUFH WKH PDQDJHPHQW
from farm to table throughout the life cycle
,Q UHVSRQVH WR WKH &29,' ZKLFK FDQ of food and build a complete food-based
FDXVH VHYHUH DFXWH UHVSLUDWRU\ LQIHFWLRQ KDYH safety net.
UDYDJHG WKH ZRUOG VLQFH WKH JRYHUQ-
ment has established the Central Epidemic ,Q RUGHU WR HQVXUH WKH VDIHW\ HIILFDF\
Command Center (referred to as the CECC) DQG TXDOLW\ RI GUXJV 7)'$ QRW RQO\ LPSOH-
to facilitate cross-functional coordination. ments product lifecycle management model
TFDA introduced advanced deployment and also actively collaborates with other
measures such as making an inventory of parties around the world to improve drug
GUXJV DQG PHGLFDO GHYLFHV DFFHOHUDWLQJ WKH ULVN DVVHVVPHQW TXDOLW\ FRQWURO DQG GLJLWDO
UHYLHZV RI HPHUJHQF\ XVH DXWKRUL]DWLRQV HV- management. TFDA also provides a regula-
tablishing project teams for consultation ser- tory environment which is harmonized with
YLFHV WUDFNLQJ WKH HVVHQWLDO VXSSOLHG IRU SDQ- LQWHUQDWLRQDO VWDQGDUGV 0HDQZKLOH 7)'$
GHPLF FRQWURO DQG DVVLVWLQJ LQ WKH UHVHDUFK actively establishes relative standards for re-
GHYHORSPHQW DQG LQWURGXFWLRQ RI SDQGHPLF generative medicine preparations to acceler-
FRQWURO GUXJV DQG PHGLFDO GHYLFHV %HVLGHV ate the development of the domestic industry
to respond to the emerging biomedical tech-
